Aniñon, Jether A.

HRN: 27-46-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2025
CEFTAZIDIME 1GM (VIAL)
07/15/2025
08/15/2025
IV
1gram
Q8h
CAP HR In Progression
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines